Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II

By Neuzil Jiri   Dyason Jeffrey   Freeman Ruth   Dong Lan-Feng   Prochazka Lubomir   Wang Xiu-Fang   Scheffler Immo   Ralph Stephen  

Journal of Bioenergetics and Biomembranes, Vol. 39, Iss. 1, 2007-02 ,pp. : 65-72

Springer Publishing Company

Access to resources Recommend Favorite

Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer

By Jiang Quan   Zheng Shilong   Wang Guangdi  

Future Medicinal Chemistry, Vol. 5, Iss. 9, 2013-06 ,pp. : 1023-1035

Future Science

Access to resources Recommend Favorite

Inhibiting the Enzymes of the Endothelin and Renin-Angiotensin Systems in Cancer

By  

Current Enzyme Inhibition, Vol. 2, Iss. 4, 2006-11 ,pp. : 353-362

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibiting CDK inhibitors: new lessons from DNA tumor viruses

By Oliver Funk J.   Galloway D.A.  

Trends in Biochemical Sciences, Vol. 23, Iss. 9, 1998-09 ,pp. : 337-341

Elsevier

Access to resources Recommend Favorite

HER-dimerization inhibitors: evaluating pertuzumab in women's cancers

By Kristjansdottir Katrin   Dizon Don  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 243-250

Informa Healthcare

Access to resources Recommend Favorite